A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
| Status: | Archived |
|---|---|
| Conditions: | Colorectal Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | December 2009 |
| End Date: | June 2011 |
A Phase 1/2 Study to Evaluate Escalating Doses of DOR201 [Enteric-Coated Oral Beclomethasone Dipropionate (BDP)] for Prevention of Signs and Symptoms of Acute Enteritis in Patients With Rectal Cancer Treated With Combined Chemotherapy and Radiation Therapy
The purpose of this study is to evaluate the safety and maximum tolerated dose of DOR201 and
the effectiveness of increasing doses of DOR201 to prevent the signs and symptoms of acute
radiation enteritis in patients with rectal cancer treated with radiation and chemotherapy.
We found this trial at
2
sites
Boston Med Center Boston Medical Center (BMC) is a 496-bed academic medical center located in...
Click here to add this to my saved trials
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
Click here to add this to my saved trials